Media Newsroom of

Diagnomics, Inc.

5775 Kearny Villa Rd.
San Diego, CA 92123

Diagnomics, Inc. is a trusted provider of innovative genetic testing platforms for both organizations and individual consumers offering comprehensive genomic solutions for the development of personalized healthcare and precision medicine.

Diagnomics Introduces ACMG 59 Reports for Personalized Genetic Testing

Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics’ portfolio of Personalized Genomics. Diagnomics has partnered with Fabric Genomics to use Fabric Enterprise, its…

Diagnomics Partners With Translational Software to Launch Pharmacogenetic Testing Services in the United States

Diagnomics Inc., a San Diego-based genomics solution provider, has extended its product portfolio to include pharmacogenetic (PGx) reporting through a strategic partnership with Translational Software Inc. (TSI). Diagnomics is one of the first companies to offer clinically validated PGx solutions on Illumina’s Global…

Diagnomics Celebrates the Announcement of the Successful Initial Public Offering (IPO) and Listing of Eone-Diagnomics Genome Center (EDGC) on the Korea Securities Dealer Automated Quotation (KOSDAQ)

Diagnomics, Inc., a leading provider for precision genomic medicine solutions proudly shares the announcement of the successful initial public offering (IPO) and listing of Eone-Diagnomics Genome Center (ticker symbol; EDGC) on the Korea Securities Dealer Automated Quotation (KOSDAQ) on June 26, 2018. Eone-Diagnomics Genome Center…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or Signup using Email

Already have an account ? Login

Reset Password

Already have an account ? Login